Sexual Health Support Program for Women With Metastatic Breast Cancer
Part of Cancer, Skin clinical trials.
This study tests an educational program designed to help women with metastatic breast cancer (cancer that has spread) improve their sexual health and function. The program focuses on addressing sexual concerns that often arise during cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You have been diagnosed with metastatic breast cancer (breast cancer that has spread)
- You are experiencing significant sexual dysfunction or concerns about your sexual health
- You are able to read and write in English
- You have regular access to the internet
- You are physically and mentally able to participate in the educational program independently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a group-based lifestyle program for women with HR+/HER2- metastatic breast cancer. The program helps you improve diet, increase physical activity, and learn mind-body practices in a supportive group setting.
This study helps patients with HER2-negative metastatic breast cancer (cancer that has spread beyond the breast) make informed treatment choices together with their doctors. The trial focuses on how shared decision-making—where you and your care team discuss options together—affects your care experience and outcomes.
This study tests a structured lifestyle program (diet and physical activity guidance) for women with metastatic breast cancer. It may help improve well-being and health behaviors, especially if you haven’t been following the recommended nutrition and activity guidelines.
This study tests a counseling program designed to help women with metastatic breast cancer build resilience and cope better. If you've been diagnosed within the last 6 months and get your cancer care at UNC, you may be eligible.
This study tests a mobile health program that provides support and information to young women with early-stage breast cancer who are on hormone therapy. The goal is to help you stay on your treatment and manage side effects.
This study tests a program to help people with metastatic breast cancer take their endocrine therapy, CDK4/6 inhibitors, and heart-related medications as prescribed. If you sometimes miss doses of these medicines, you may be able to join.
Hear when a new Metastatic Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.